Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Accounts Payables: 2020-2022

Historic Accounts Payables for Atea Pharmaceuticals (AVIR) over the last 2 years, with Sep 2022 value amounting to $1.1 million.

  • Atea Pharmaceuticals' Accounts Payables fell 94.96% to $1.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.1 million, marking a year-over-year decrease of 94.96%. This contributed to the annual value of $4.5 million for FY2021, which is 7456.67% up from last year.
  • According to the latest figures from Q3 2022, Atea Pharmaceuticals' Accounts Payables is $1.1 million, which was down 91.95% from $13.9 million recorded in Q2 2022.
  • Atea Pharmaceuticals' Accounts Payables' 5-year high stood at $22.2 million during Q3 2021, with a 5-year trough of $60,000 in Q4 2020.
  • Its 3-year average for Accounts Payables is $7.2 million, with a median of $4.5 million in 2020.
  • In the last 5 years, Atea Pharmaceuticals' Accounts Payables spiked by 7,456.67% in 2021 and then crashed by 94.96% in 2022.
  • Over the past 3 years, Atea Pharmaceuticals' Accounts Payables (Quarterly) stood at $60,000 in 2020, then soared by 7,456.67% to $4.5 million in 2021, then slumped by 94.96% to $1.1 million in 2022.
  • Its last three reported values are $1.1 million in Q3 2022, $13.9 million for Q2 2022, and $3.7 million during Q1 2022.